VTVT
VTVT
NASDAQ · Biotechnology

Vtv Therapeutics Inc- Cl A

$29.02
-1.99 (-6.42%)
As of Feb 8, 2:08 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 10.92M 10.43M 9.09M
Net Income 2.59M 2.46M 2.32M
EPS
Profit Margin 23.7% 23.6% 25.5%
Rev Growth +16.5% +12.7% +12.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 70.20M 73.02M 57.41M
Total Equity 53.23M 50.37M 60.82M
D/E Ratio 1.32 1.45 0.94
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 3.77M 3.49M 2.84M
Free Cash Flow 3.86M 3.25M 2.35M